Welcome to our dedicated page for Cellebrite Di news (Ticker: CLBT), a resource for investors and traders seeking the latest updates and insights on Cellebrite Di stock.
Cellebrite DI Ltd (NASDAQ: CLBT) provides authoritative digital intelligence solutions to law enforcement and enterprises worldwide. This news hub offers investors and professionals a centralized resource for tracking corporate developments, technological advancements, and strategic initiatives shaping the digital forensics sector.
Access timely updates including earnings reports, product launches, partnership announcements, and regulatory filings. Our curated collection ensures stakeholders stay informed about critical developments affecting investigative technology markets, cybersecurity trends, and Cellebrite’s position as a leader in legally sanctioned data analysis solutions.
Key updates cover innovations in mobile device forensics, cloud data extraction tools, and enterprise-grade investigative platforms. Regular monitoring of this page provides insights into Cellebrite’s subscription revenue growth, global expansion efforts, and responses to evolving data privacy regulations.
Bookmark this page for structured access to CLBT’s official communications and third-party analysis. Combine technical understanding of digital intelligence markets with strategic business insights through our maintained news archive.
Cellebrite has launched an automated system that integrates investigative analytics, enabling stakeholders to collect, review, and analyze data efficiently. This innovation aims to resolve cases quicker and enhance the workflow for examiners, analysts, and prosecutors by securely storing and decoding evidence. The company's Executive Vice President stated that this system can save hours in the data transfer process, ultimately accelerating justice. Cellebrite, traded on NASDAQ under the symbol CLBT, is committed to enhancing digital investigations.
Cellebrite reported a strong second quarter for 2022, with revenue of $62.6 million, a 6% increase year-over-year, and Annual Recurring Revenue (ARR) of $214 million, reflecting a 35% year-over-year growth. Subscription revenue grew by 20%. However, revenues fell short of expectations due to extended sales cycles and challenges in transitioning to a subscription model. The company has adjusted its full-year revenue forecast to $270-$285 million, down from $285-$300 million. Despite these challenges, management remains optimistic about long-term growth and profitability.
Cellebrite (NASDAQ: CLBT) announced that it will release its second quarter 2022 financial results on August 11, 2022, prior to market opening. A conference call is scheduled for the same day at 8:30 a.m. ET, where management will discuss the financial outcomes. Participants can register in advance to receive dial-in information. Cellebrite aims to enhance Digital Intelligence solutions for public and private sectors, focusing on digital investigations. The company's mission emphasizes protecting lives, accelerating justice, and maintaining privacy globally.
Cellebrite DI Ltd. (NASDAQ: CLBT) and Chainalysis have announced a partnership to enhance digital investigations by integrating cryptocurrency-related tools. This collaboration aims to help law enforcement and corporations address illicit cryptocurrency activities effectively. The solution will provide real-time data and streamline investigation workflows. Additionally, the companies will offer training and expertise in cryptocurrency investigations. The integrated solution is expected to launch in Q3 2022, enhancing tools available for combatting blockchain-related crime.
Cellebrite DI Ltd. (Nasdaq: CLBT) has launched the Cellebrite Physical Analyzer Ultra Series and a SaaS-based Cellebrite Premium, enhancing their digital investigation capabilities. The PA Ultra Series processes larger volumes of data more efficiently, enabling quicker case resolution and supporting cryptocurrency data enrichment. The SaaS version offers a comprehensive cloud-based solution for data management in investigations. These innovations solidify Cellebrite's position as a leader in Digital Intelligence solutions for public and private sectors.
Cellebrite (NASDAQ: CLBT) reported a strong Q1 2022 with revenue of $62.4 million, marking a 17% increase year-over-year, and Annual Recurring Revenue (ARR) of $201 million, up 33%. The company's subscription revenue reached $48.2 million, reflecting a 19% growth. Cellebrite reiterated its 2022 outlook, expecting revenue between $285-300 million, representing 16-22% growth. The positive business environment is attributed to rising investments in Digital Intelligence solutions, and recent partnerships aim to enhance their offerings. GAAP net income stood at $55.4 million.
Cellebrite DI Ltd. (NASDAQ: CLBT) announced the launch of its cloud-based Cellebrite Premium service, aimed at enhancing access capabilities for law enforcement agencies. This SaaS version offers cost-effective licensing, reduces hardware needs, and provides timely updates for digital investigations. The offering will be showcased at the Techno Security & Digital Forensics Conference from May 9-12, 2022. Ronnen Armon, Chief Products & Technologies Officer, emphasized the importance of equipping agencies to manage increasing digital evidence.
Cellebrite DI Ltd. (NASDAQ: CLBT) has been recognized as a Leader in the IDC MarketScape: Worldwide Digital Forensics in Public Safety 2022 Vendor Assessment. The report evaluated six vendors on 11 core capabilities, highlighting Cellebrite's significant R&D investment, unmatched device support, and user-friendly technology. Customers praised its cloud delivery models and IP in visual analytics. The recognition underscores the importance of Cellebrite's solutions in modern law enforcement investigations, reflecting its commitment to innovation in digital intelligence.
Cellebrite (Nasdaq: CLBT) announced a USD 2 million agreement with a national police force in EMEA to enhance its digital intelligence capabilities, deploying over 100 UFED end point licenses. This expansion marks one of the largest Cellebrite Premium Enterprise deployments, aimed at reducing case backlogs and improving investigative efficiency. Arthur Veinstein, General Manager of International Business, noted that this modernization effort will foster better collaboration among examiners and investigators.
Cellebrite (Nasdaq: CLBT) announced it will report Q1 2022 financial results on May 12, 2022, before market open. A conference call is scheduled for 8:30 AM ET to discuss the results. Cellebrite specializes in Digital Intelligence solutions, significantly aiding public and private sector investigations. The company aims to enhance data management processes for legally sanctioned investigations, establishing itself as a trusted provider globally.
FAQ
What is the current stock price of Cellebrite Di (CLBT)?
What is the market cap of Cellebrite Di (CLBT)?
